Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed announced on October 5, 2021, that it has granted inducement awards to 11 new employees.

Rhea-AI Summary

Insmed announced on October 5, 2021, that it has granted inducement awards to 11 new employees. These awards consist of options to purchase a total of 67,760 shares of common stock at an exercise price of $27.38, the closing price on the grant date. The options feature a ten-year term with a four-year vesting schedule, where 25% vests after the first year and 12.5% every six months thereafter, contingent on continued employment. This initiative is aligned with NASDAQ Listing Rule 5635(c)(4).

Argus Session date unavailable

+0.30% session move Open Argus

Details

News Market Reaction – INSM

The recorded move for INSM in the trading session of this news was +0.30%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., Oct. 5, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 11 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.

In connection with the commencement of their employment, the employees received options on October 1, 2021 to purchase an aggregate 67,760 shares of Insmed common stock at an exercise price of $27.38 per share, the closing trading price on the Nasdaq Global Select Market on the date of grant.

The options have a ten-year term and a four-year vesting schedule, with 25% of the shares subject to the option vesting on the first anniversary of the relevant grant date and 12.5% of the shares subject to the option vesting every six months thereafter through the fourth anniversary of the relevant grant date, subject to the relevant employee's continued service with Insmed on the applicable vesting date.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com 

Media:

Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301391884.html

SOURCE Insmed Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the details of Insmed's recent employee inducement awards on October 5, 2021?

Insmed granted inducement awards to 11 new employees, providing options to purchase 67,760 shares at $27.38 per share, with a ten-year term and a four-year vesting schedule.

How many shares were awarded to new employees by Insmed?

A total of 67,760 shares of common stock were awarded to 11 new employees.

What is the exercise price of the stock options granted by Insmed?

The exercise price of the stock options granted by Insmed is $27.38 per share.

What is the vesting schedule for the stock options granted by Insmed?

The options vest 25% after the first year, with 12.5% vesting every six months until the fourth anniversary.